Director Yemin Ezra Uzi reported an insider sale of Delek US Holdings, Inc. common stock (NASDAQ: DK) on March 4, 2026, according to a Form 4 filing with the Securities and Exchange Commission.
The filing details two components to the disposition. Mr. Uzi directly sold 18,139 shares of Delek common stock at a weighted average sale price of $43.17, generating proceeds of $783,058. Separately, 66,511 shares that were held indirectly by Yemin Investments, LP were sold at the same weighted average price of $43.17, producing $2,871,282 in proceeds. Combined, the total number of shares sold was 84,650 for aggregate proceeds of $3,654,340.
The reported sale price reflects a weighted-average across multiple trades with execution prices ranging from a low of $43.00 per share to a high of $43.57 per share.
Following the completion of these transactions, the filing shows that Mr. Uzi directly holds 240,281 shares of Delek US Holdings and retains indirect ownership of 613,145 shares.
The securities were sold pursuant to a pre-arranged 10b5-1 trading plan that Mr. Uzi adopted on December 3, 2025. The Form 4 indicates the sales were executed under that pre-established arrangement rather than as ad hoc trades.
These insider moves arrive against a backdrop of pronounced share-price appreciation for Delek US Holdings. InvestingPro data cited in the filing notes that the company's stock has climbed more than 209% over the past year. The stock was trading at $42.29 at the time of the filing, and InvestingPro analysis included in the report flagged the company as appearing overvalued at those levels.
Investors and analysts have also had fresh financial data to digest. Delek reported fourth-quarter 2025 results that featured a notable earnings surprise. The company announced adjusted earnings per share (EPS) of $2.31 for the quarter, substantially beating the consensus expectation of a loss of $0.07 per share. That gap represents a positive surprise of roughly 3,400% relative to the prior consensus figure disclosed in the report.
On the revenue side, Delek posted $2.43 billion for the quarter, missing the anticipated $2.55 billion figure. That shortfall is a negative surprise of approximately 4.71% as presented in the filing summary. The combination of an outsized EPS beat and a revenue miss produced an overall mixed set of operating metrics for the period.
Market reaction to the quarterly disclosures was characterized as positive in the filing's summary of events. The report noted that analyst firms may revisit or adjust their outlooks in light of the results, but no specific upgrades or downgrades were cited in the documentation.
Below are the core transaction figures disclosed on the Form 4:
- Date of sale: March 4, 2026
- Direct sale: 18,139 shares at a weighted average price of $43.17, totaling $783,058
- Indirect sale (Yemin Investments, LP): 66,511 shares at a weighted average price of $43.17, totaling $2,871,282
- Price range of trades: $43.00 to $43.57
- Total shares sold: 84,650
- Total proceeds: $3,654,340
- 10b5-1 plan adopted: December 3, 2025
- Post-sale holdings: Direct – 240,281 shares; Indirect – 613,145 shares
The filing and the quarterly results provide investors with concrete data points on insider liquidity, company earnings performance, and prevailing market sentiment. Observers tracking insider activity and quarterly financials will consider these disclosures as part of a broader assessment of Delek's recent trajectory.